Summary

The global Live Cell Shipper market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Live Cell Shipper leading manufacturers including PHC Europe B.V., Cellbox Solutions, Biomedical Polymers, Daniels Healthcare, Genomic Industry, Greiner Bio-One, Kartell S.p.A., KGW-Isotherm, Macopharma, Tritech Forensics, etc., dominate supply; the top five capture approximately % of global revenue, with PHC Europe B.V. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Live Cell Shipper market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
PHC Europe B.V.
Cellbox Solutions
Biomedical Polymers
Daniels Healthcare
Genomic Industry
Greiner Bio-One
Kartell S.p.A.
KGW-Isotherm
Macopharma
Tritech Forensics
PLASTI LAB
Sarstedt
Simport Scientific
Segment by Type
Manual Temperature-controlled
Automatic Temperature-controlled
Segment by Application
Hospital
Laboratory
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Live Cell Shipper study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Live Cell Shipper: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Live Cell Shipper Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Manual Temperature-controlled
1.2.3 Automatic Temperature-controlled
1.3 Market Segmentation by Application
1.3.1 Global Live Cell Shipper Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Live Cell Shipper Revenue Estimates and Forecasts 2020-2031
2.2 Global Live Cell Shipper Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Live Cell Shipper Sales Estimates and Forecasts 2020-2031
2.4 Global Live Cell Shipper Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Live Cell Shipper Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Live Cell Shipper Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Manual Temperature-controlled Market Size by Manufacturers
3.5.2 Automatic Temperature-controlled Market Size by Manufacturers
3.6 Global Live Cell Shipper Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Live Cell Shipper Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Live Cell Shipper Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Live Cell Shipper Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Live Cell Shipper Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Live Cell Shipper Sales and Revenue by Type (2020-2031)
6.4 North America Live Cell Shipper Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Live Cell Shipper Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Live Cell Shipper Sales and Revenue by Type (2020-2031)
7.4 Europe Live Cell Shipper Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Live Cell Shipper Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Live Cell Shipper Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Live Cell Shipper Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Live Cell Shipper Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Live Cell Shipper Sales and Revenue by Type (2020-2031)
9.4 Central and South America Live Cell Shipper Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Live Cell Shipper Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Live Cell Shipper Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Live Cell Shipper Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Live Cell Shipper Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 PHC Europe B.V.
11.1.1 PHC Europe B.V. Corporation Information
11.1.2 PHC Europe B.V. Business Overview
11.1.3 PHC Europe B.V. Live Cell Shipper Product Models, Descriptions and Specifications
11.1.4 PHC Europe B.V. Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 PHC Europe B.V. Live Cell Shipper Sales by Product in 2024
11.1.6 PHC Europe B.V. Live Cell Shipper Sales by Application in 2024
11.1.7 PHC Europe B.V. Live Cell Shipper Sales by Geographic Area in 2024
11.1.8 PHC Europe B.V. Live Cell Shipper SWOT Analysis
11.1.9 PHC Europe B.V. Recent Developments
11.2 Cellbox Solutions
11.2.1 Cellbox Solutions Corporation Information
11.2.2 Cellbox Solutions Business Overview
11.2.3 Cellbox Solutions Live Cell Shipper Product Models, Descriptions and Specifications
11.2.4 Cellbox Solutions Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cellbox Solutions Live Cell Shipper Sales by Product in 2024
11.2.6 Cellbox Solutions Live Cell Shipper Sales by Application in 2024
11.2.7 Cellbox Solutions Live Cell Shipper Sales by Geographic Area in 2024
11.2.8 Cellbox Solutions Live Cell Shipper SWOT Analysis
11.2.9 Cellbox Solutions Recent Developments
11.3 Biomedical Polymers
11.3.1 Biomedical Polymers Corporation Information
11.3.2 Biomedical Polymers Business Overview
11.3.3 Biomedical Polymers Live Cell Shipper Product Models, Descriptions and Specifications
11.3.4 Biomedical Polymers Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Biomedical Polymers Live Cell Shipper Sales by Product in 2024
11.3.6 Biomedical Polymers Live Cell Shipper Sales by Application in 2024
11.3.7 Biomedical Polymers Live Cell Shipper Sales by Geographic Area in 2024
11.3.8 Biomedical Polymers Live Cell Shipper SWOT Analysis
11.3.9 Biomedical Polymers Recent Developments
11.4 Daniels Healthcare
11.4.1 Daniels Healthcare Corporation Information
11.4.2 Daniels Healthcare Business Overview
11.4.3 Daniels Healthcare Live Cell Shipper Product Models, Descriptions and Specifications
11.4.4 Daniels Healthcare Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Daniels Healthcare Live Cell Shipper Sales by Product in 2024
11.4.6 Daniels Healthcare Live Cell Shipper Sales by Application in 2024
11.4.7 Daniels Healthcare Live Cell Shipper Sales by Geographic Area in 2024
11.4.8 Daniels Healthcare Live Cell Shipper SWOT Analysis
11.4.9 Daniels Healthcare Recent Developments
11.5 Genomic Industry
11.5.1 Genomic Industry Corporation Information
11.5.2 Genomic Industry Business Overview
11.5.3 Genomic Industry Live Cell Shipper Product Models, Descriptions and Specifications
11.5.4 Genomic Industry Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Genomic Industry Live Cell Shipper Sales by Product in 2024
11.5.6 Genomic Industry Live Cell Shipper Sales by Application in 2024
11.5.7 Genomic Industry Live Cell Shipper Sales by Geographic Area in 2024
11.5.8 Genomic Industry Live Cell Shipper SWOT Analysis
11.5.9 Genomic Industry Recent Developments
11.6 Greiner Bio-One
11.6.1 Greiner Bio-One Corporation Information
11.6.2 Greiner Bio-One Business Overview
11.6.3 Greiner Bio-One Live Cell Shipper Product Models, Descriptions and Specifications
11.6.4 Greiner Bio-One Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Greiner Bio-One Recent Developments
11.7 Kartell S.p.A.
11.7.1 Kartell S.p.A. Corporation Information
11.7.2 Kartell S.p.A. Business Overview
11.7.3 Kartell S.p.A. Live Cell Shipper Product Models, Descriptions and Specifications
11.7.4 Kartell S.p.A. Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Kartell S.p.A. Recent Developments
11.8 KGW-Isotherm
11.8.1 KGW-Isotherm Corporation Information
11.8.2 KGW-Isotherm Business Overview
11.8.3 KGW-Isotherm Live Cell Shipper Product Models, Descriptions and Specifications
11.8.4 KGW-Isotherm Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 KGW-Isotherm Recent Developments
11.9 Macopharma
11.9.1 Macopharma Corporation Information
11.9.2 Macopharma Business Overview
11.9.3 Macopharma Live Cell Shipper Product Models, Descriptions and Specifications
11.9.4 Macopharma Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Macopharma Recent Developments
11.10 Tritech Forensics
11.10.1 Tritech Forensics Corporation Information
11.10.2 Tritech Forensics Business Overview
11.10.3 Tritech Forensics Live Cell Shipper Product Models, Descriptions and Specifications
11.10.4 Tritech Forensics Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Tritech Forensics Recent Developments
11.11 PLASTI LAB
11.11.1 PLASTI LAB Corporation Information
11.11.2 PLASTI LAB Business Overview
11.11.3 PLASTI LAB Live Cell Shipper Product Models, Descriptions and Specifications
11.11.4 PLASTI LAB Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 PLASTI LAB Recent Developments
11.12 Sarstedt
11.12.1 Sarstedt Corporation Information
11.12.2 Sarstedt Business Overview
11.12.3 Sarstedt Live Cell Shipper Product Models, Descriptions and Specifications
11.12.4 Sarstedt Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Sarstedt Recent Developments
11.13 Simport Scientific
11.13.1 Simport Scientific Corporation Information
11.13.2 Simport Scientific Business Overview
11.13.3 Simport Scientific Live Cell Shipper Product Models, Descriptions and Specifications
11.13.4 Simport Scientific Live Cell Shipper Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Simport Scientific Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Live Cell Shipper Industry Chain
12.2 Live Cell Shipper Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Live Cell Shipper Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Live Cell Shipper Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Live Cell Shipper Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Live Cell Shipper Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details